The annulus is a septin-based ring structure located at the junction of the midpiece (MP) and the principal piece (PP) of spermatozoa flagellum. In the mouse, deletion of Septin 4, a structural component of the sperm annulus, prevents annulus formation and leads to MP-PP disjunction, flagellar bending, asthenozoospermia and male sterility. Testis anion transporter 1 (Tat1) is a germ cell-specific member of the SLC26 anion transporter family and is co-expressed with Septin 4 at the sperm annulus. Interestingly, Tat1 null sperm bear an atrophic annulus, causing a phenotype similar to that of Sept4 null sperm. We searched for Tat1 misexpression and/or mislocalization in spermatozoa from asthenozoospermic subjects (n ¼ 75) and controls by performing an immunofluorescence detection assay on sperm smear preparations. We found one patient showing moderate asthenozoospermia, with 97% of sperm lacking Tat1, Septin 4 and Septin 7 proteins at the annulus. We confirmed the absence of the annulus structure by transmission electron microscopy and observed that spermatozoa from the patient displayed MP-PP disjunction and abnormal mitochondrial organization. We show that the structural defects in sperm are not caused by abnormal transcription or point mutations of the TAT1 and SEPT4 genes; however, although both proteins are expressed, they are not properly localized at sperm annulus. The case we studied, so far unreported in human, confirms the involvement of Tat1 and Septin proteins in the constitution of the annulus, but also raises questions about the function of this structure in human sperm motility.
Introduction
Asthenozoospermia is one of the major causes of male infertility and in some cases is associated with major morphological abnormalities of the flagella. Misassembly of the axoneme (Afzelius and Eliasson, 1979; Escalier, 1984; Chemes et al., 1998; Mitchell et al., 2006; Moretti et al., 2008) or misassembly of the accessory flagellar structures, particularly of the fibrous sheath (Escalier, 2003) , can cause abnormal sperm cell motility and in some cases severe asthenozoospermia (Escalier, 2006a, b, c; Escalier and Albert, 2006) . Although a genetic basis has been suggested for these human sperm flagellar abnormalities (Chemes, 2000; Baccetti et al., 2001 Baccetti et al., , 2002 Chemes and Rawe, 2003) , sequence variations and expression anomalies have been described for few genes coding for structural proteins constituting the flagella (Baccetti et al., 1981; Baccetti et al., 2001; Peknicova et al., 2007; Zuccarello et al., 2008a, b) .
Mouse gene targeting is a powerful approach to identifying genes essential for physiological processes; in particular, more than 300 mouse models have provided information about genes required for male fertility (Grootegoed et al., 1998; Okabe et al., 1998; Escalier, 2001 Escalier, , 2006a Matzuk and Lamb, 2002; Roy and Matzuk, 2006) , including several genes required for sperm flagellar assembly and motility (Escalier, 2006a, b, c) . Although the etiology of human male infertility is very complex and may only rarely result from deregulation of a single gene, each gene identified by work with mutant mouse models is potentially of interest for investigations of the genetic causes of human male infertility (Carrell et al., 2006; Cavallini et al., 2008) . We and two other groups have used a homologous recombination gene targeting strategy to determine the functions of testis anion transporter 1 (Tat1) (Toure et al., 2007) and Septin 4 (Sept4) (Ihara et al., 2005; Kissel et al., 2005) , respectively, in the mouse; we found that these proteins are located at the sperm annulus and required for † All authors have seen and approved the content of the article to be submitted; this work has not been submitted for publication elsewhere. sperm motility in the mouse (Ihara et al., 2005; Kissel et al., 2005; Toure et al., 2007) .
The annulus is an electron-dense ring-shaped structure located at the junction of the midpiece (MP) and principal piece (PP) of sperm flagella; its function has not yet been clearly established. The annulus may constitute a diffusion barrier preventing molecules in the MP and those in the PP mixing and thus conferring the compartmentalized characteristic of sperm tail required for fertilization (Myles et al., 1984; Cesario and Bartles, 1994) . Another possibility is that the annulus is required for MP organization and, in particular, facilitates mitochondrial migration and alignment along the axoneme (Phillips, 1977) .
Septins are small GTPase proteins forming homo/heteropolymers and associating with cellular membranes, actin and the microtubule cytoskeleton (Kinoshita, 2006; Spiliotis and Nelson, 2006; Weirich et al., 2008) . They have recently been recognized as being essential structural components of human and mouse annulus (Sept1, Sept4, Sept6, Sept7 and Sept12) (Ihara et al., 2005; Kissel et al., 2005; Steels et al., 2007) . Inactivation of Sept4 in the mouse results in male infertility associated with a complete absence of the annulus structure, a hairpin-like bending of the flagellum at the MP -PP junction and a total lack of sperm motility (Ihara et al., 2005; Kissel et al., 2005) .
We have shown that in the mouse, inactivation of Tat1, a new germ cell-specific member of the SLC26 family (Toure et al., 2007) , is deleterious to male fertility and that the phenotype induced is very similar to that of Sept4 null males. Tat1 null sperm completely lack motility and hyperactivation under capacitating conditions; they also display hairpin-like bending of the flagella with structural defects of the annulus. Consistent with this phenotype, Tat1 is co-expressed with Sept4 at the annulus of both human and mouse mature sperm in addition to being expressed during spermatogenesis (spermatocytes and spermatids) (Toure et al., 2007) .
These various findings strongly suggest that the annulus is essential for sperm motility in the mouse. Furthermore, analysis of a Japanese cohort of 15 infertile patients revealed annulus disorganization and Septin 7 mislocalization in three cases of isolated asthenozoospermia (Ihara et al., 2005) . If confirmed, this apparently frequent phenotype could be useful as a diagnostic marker to classify asthenozoospermia syndrome and also to identify suitable candidate genes for further investigation of this pathology. As part of our studies on the involvement of Tat1 in human asthenozoospermia, we screened sperm smear preparations from asthenozoospermic semen samples for TAT1 immunoreactivity. Here, we describe the phenotype of a patient displaying a lack of Tat1, Septin 4 and Septin 7 proteins at the sperm annulus together with a complete absence of the annulus and MP -PP disjunction.
Materials and Methods

Subjects
This study was conducted in accordance with Hospital ethical guidelines and each participant analyzed in this study gave written informed consent.
We evaluated a cohort of 75 subjects consulting for sterility and displaying asthenozoospermia. Asthenozoospermic samples were defined as those with ,25% progressive motility (grade a) or ,50% motile sperm (grades a þ b) (World Health Organization, 1999) . Among the 75 samples, 28 samples displayed isolated asthenozoospermia, 13 displayed oligo-asthenozoospermia (concentration ,20 million/ml) and 34 displayed terato-asthenozoospermia with morphological defects restricted to the flagellum.
Semen analysis
All samples were prepared and evaluated following WHO standard criteria. Semen samples were obtained by masturbation after 2 -5 days of abstinence, and routine semen analysis was performed after liquefaction of the semen within 30 min at 378C. For each sperm sample, sperm viability was assessed with eosin staining, sperm morphology was assessed by Giemsa staining and sperm motility was assessed by counting 200 spermatozoa.
In vitro capacitation assay
Aliquots of 4 Â 10 6 spermatozoa from fresh ejaculated semen samples were washed in an equal volume of Ferticult-IVF medium (FertiPro NV, Beernem, Belgium), resuspended in 1 ml of Ferticult-IVF medium and incubated for 3 h at 378C in 5% CO 2 . Sperm were then washed with the same medium containing 1 mM Na 3 VO 4 and 5 mM inorganic pyrophosphate (Ppi). Protein extracts were obtained by lysis in Laemmli buffer, then resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS -PAGE) (2.5 Â 10 6 cells/lane) and transferred to nitrocellulose membranes for anti-phosphotyrosine immunoblotting with 4G10 antibody (1:1000).
Immunofluorescence of sperm smear preparations
Aliquots of 20 ml of fresh sperm were spread on Superfrost Plus slides (Menzel Glasbearbeitungswerk, GmbH & Co. KG, Braunschweig, Germany), briefly dried and fixed for 10 min in cold methanol/acetone (3/1). After permeabilization of the cells with 0.1% Triton in phosphatebuffered saline (PBS), the slides were blocked in 1% bovine serum albumin in PBS for 1 h, and incubated with primary antibodies (rabbit anti-Tat1, Septin 4 or Septin 7) for 2 h at room temperature (dilution 1:100). After three washes of 5 min in PBS, the slides were incubated with Alexa Fluor w 488 goat anti-rabbit antibody (Invitrogen Co., Carlsbad, USA) (dilution 1:1000) for 1 h at room temperature. After three washes of 5 min in PBS, the slides were mounted in Vectashield medium (Vector Laboratories, Burlingame, USA) containing 0.5 mg/ml of 4 0 ,6-diamidino-2-phenylindole.
For labeling of the MP, we added 500 nM of the mitotracker dye Red 580 (Molecular Probes, Inc., Eugene, USA) during the incubation with the secondary antibodies.
Slides were analyzed with a Zeiss Axiophot epifluorescence microscope; all images were digitally acquired with a cooled charge-coupled device camera (Hamamatsu Co., Japan), under identical instrument settings.
Transmission electron microscopy analysis
Semen samples were washed in M16 medium (Sigma-Aldrich Co. Ltd, Irvine, UK), centrifuged at 300g for 10 min and fixed in 0.1 M phosphate buffer pH 7 containing 3% glutaraldehyde (Grade I; Sigma-Aldrich Co.) for 1.5 h at room temperature. The samples were then washed twice in PBS with 1% sucrose and resuspended in 0.2 M sodium cacodylate buffer. Secondary fixation was performed using 1% osmium tetra-oxide (Agar Scientific Ltd, Essex, UK), after which samples were dehydrated in graded alcohol and embedded in Epon resin (Polysciences Inc., Warrington, USA). Semi-thin sections were stained with toluidine blue-Azur II and examined on a Zeiss Axioscope photomicroscope (Carl Zeiss, GmbH, Jena, Germany). Ultra-thin sections (90 nm) were cut with a Reichert OmU2 ultramicrotome (Reichert-Jung AG, Wien, Austria) using a diamond knife, mounted on nickel grids, stained with uranyl acetate and lead citrate, and examined using a JEOL JEM 100CX II electron microscope (Jeol Ltd, Tokyo, Japan) operated at 80 kV. Photographs were taken on Kodak electron microscopy film (Kodak, Rochester, New York, USA). Negatives were scanned using an Epson Perfection 4990 photo flat-bed scanner (600 dpi) with a transparency attachment (Seiko Epson Corporation, Nagano, Japan). Digitalized images were processed using Adobe Photoshop software (Adobe Systems Inc., San Jose, CA, USA).
RT-PCR analysis
Lymphoblastoid cell lines from the patient and two control subjects (healthy blood donors) were obtained by Epstein-Barr virus transformation of lymphocytes isolated from peripheral blood. Total RNA was extracted from lymphoblastoid cell lines with Trizol Reagent (Invitrogen Life Technologies Co., Carlsbad, USA). cDNA was synthesized using 2 mg of total RNA incubated with 50 ng of oligo(dT) 12 -18 primer, 0.5 mM of dNTPs mix, 0.01 M of dithiothreitol and 1 ml (200 U) of SuperScript II RT (Invitrogen, BV NV, Leek, Netherlands) at 428C for 2 h. PCR was performed using 5 ml of cDNA template and the appropriate primers for Sept1 (product size 308 bp), Sept4 (272 bp), Sept6 (372 bp), Sept7 (429 bp) and Sept12 (300 bp). For Tat1, we performed nested PCR (SlcF2/R2; 279 bp) on 5 ml of primary PCR products (SlcF1/R1). We also performed hypoxanthine-guanine phosphoribosyltransferase (Hprt, 352 bp) amplification for quality and quantity control of the cDNA preparation. 
Sperm protein analysis
Semen samples (10 Â 10 6 spermatozoa) from patient and control were washed in PBS, centrifuged at 1000g and incubated in 25 ml of Laemmli buffer at 958C for 10 min. The samples were then resolved by SDS -PAGE and transferred to nitrocellulose membrane for immunodetection with rabbit anti-Tat1 antibody (dilution 1:500) and mouse anti-tubulin antibody (dilution 1:5000). COS cells transiently transfected with mock (pRK5) or TAT1 full-length expressing vector (pRK5-TAT1) were used as control for TAT1 antibody specificity; 15 mg/lane of protein extract from each cell type were loaded on the gel.
Antibodies
Tat1 antibody was raised in rabbit against human TAT1 amino acids 664 -970 (Toure et al., 2001) . Septin 4 (sc-20179) and Septin 7 (sc-20620) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, USA). Mouse anti-b-tubulin antibody (clone AA2) was purchased from Upstate/ Millipore (Edinburgh, UK).
Goat anti-rabbit antibody conjugated with Alexa 488 was purchased from Invitrogen Co. Anti-phosphotyrosine antibody, clone 4G10, was purchased from Upstate/Millipore (Edinburgh, UK) and anti-rabbit conjugated with horse-radish peroxidase from DAKO Inc. (Carpinteria, USA).
Results
To investigate TAT1 in cases of human asthenozoospermia, we screened asthenozoospermic semen samples for abnormal expression and/or localization of TAT1. We used an immunofluorescence detection assay on sperm smear preparations from 75 asthenozoospermic subjects and found one patient with a complete absence of TAT1 staining at the annulus of 97% of the spermatozoa present in the semen sample (Fig. 1) .
The patient was 31 years old at the time of the observation; he had been married for 44 months to a 28-year-old woman and the couple first consulted for infertility after 10 months of unsuccessful attempts to obtain a pregnancy. According to the WHO standard criteria, the first semen analysis indicated normal total volume (5.5 ml), normal pH (7.9), normal concentration (43 millions/ml) and normal viability (80%) values; however spermatozoa showed reduced sperm motility (progressive motility grades a þ b: 35%) together with a low yield of progressively motile sperm recovered after selection on density gradient centrifugation (0.7 Â 10 6 cells) and teratozoospermia (19% of typical forms; 30% of spermatozoa displaying abnormal-skinny or angulated-MP). There were few round cells present in the sample (0.3 Â 10 6 cells/ml) so leucospermia or epithelium desquamation was rejected; investigations for bacteria and mycoplasma contamination of semen were also both negative. During follow-up, two semen evaluations were repeated and similar values were obtained: total volume: 5.6 -3.5 ml, pH values: 7.4-7.9, concentration: 94 -66 million/ml, viability: 88 -82%, motility (grades a þ b): 30-25% and teratozoospermia: 20-19% of typical forms; 40-48% of spermatozoa with abnormal MP. Computer-aided semen analysis of the third semen sample indicated 29% motile cells and 12% rapid cells. Curvilinear velocity (59.9 mm/s), straight-line velocity (23.8 mm/s) and linearity (41%) were lower than normal published values. However, sperm progression in cervical mucus was normal.
There was no consanguinity and no family cases of infertility in the patient's history. The patient had no genito-urinary infections, nor previous testicular injury; however, he suffered from hypertension and renal hypertrophy, which were not treated at the time of observation. During the third visit, the patient informed us of the recent pregnancy of his partner; with the consent of the patient, we continued our investigations.
We used anti-Tat1 antibodies to test the semen sample provided at the third visit and observed the absence of Tat1 staining at the annulus, confirming the finding of the first evaluation. We also performed an in vitro capacitation assay: a sample of semen was incubated in capacitating medium for 3 h at 378C and the phosphotyrosine pattern was analyzed by western blotting. The sample showed the typical hyperphosphorylated protein profile associated with capacitation, suggesting that although sperm motility was impaired, the ability of the sperm to undergo capacitation at the flagellar level was intact (Fig. 2) .
We then tested for the presence of Sept4 and Sept7, proteins which, together with Sept1, Sept6 and Sept12, are structural components of human and mouse sperm annulus (Ihara et al., 2005; Kissel et al., 2005; Steels et al., 2007) . Immunofluorescence assays of sperm smear preparations failed to detect either Sept4 or Sept7 at the annulus, suggesting that the annulus was absent (Fig. 1) .
To confirm this finding, we examined fresh ejaculated sperm samples by transmission electron microscopy: the annulus structure was completely absent from all spermatozoa analyzed. Furthermore, we observed substantial disorganization of the MP with an abnormal arrangement of mitochondria in 93% of the spermatozoa analyzed, and apparent disjunction between the MP and the PP in 42% of the spermatozoa analyzed (Fig. 3) . We also recorded the absence of peripheral doublets in 50% of the axonemes. This structural analysis indicated that the asthenozoospermia observed in the patient was associated with the absence of the annulus and severe flagellar disorganization.
To search for the possible causes of these structural defects, we investigated the expression and gene sequence of known components of the annulus.
We first analyzed the mRNAs for Sept1, Sept4, Sept6, Sept7 and Sept12 by performing RT -PCR with RNA extracted from lymphoblastoïd cell lines created using patient's (and controls') blood; all these mRNAs were present in both samples from the patient and controls. Tat1 gene being exclusively expressed in male germ cells, we performed nested RT -PCR (a two-step procedure based on a large number of amplification cycles, which is commonly used to detect illegitimate transcription of genes in tissues where they are normally not expressed); similar to Septins, we found the presence of Tat1 illegitimate transcripts in blood cells from the patient (Fig. 4) .
We next screened the full coding regions of the TAT1 and SEPT4 genes for point mutations. We analyzed the TAT1 gene sequence by denaturing high-pressure liquid chromatography (DHPLC) and sequencing, and found several variations: p.M73V, p.V639I, IVS16þ78 insA and IVS10 þ 27A . G; all of which correspond to previously described polymorphisms (our unpublished data, Makela et al., 2005) . Consistent with this result, TAT1 western blot analysis on sperm protein extracts from the patient reveals the previously described hyperglycosylated pattern (Toure et al., 2001) , thus suggesting that TAT1 protein is expressed but failed to localize at the annulus (Supplementary data, Fig. S1 ).
We also sequenced the SEPT4 coding region, which encodes two splicing isoforms (ARTS and H5), and found the sequence variant DT1565 in the 3 0 untranslated region of the ARTS isoform. We used SEPT4 antibodies and western blotting to test the effect of this sequence variation in blood protein extracts from the patient. The results for the patient were similar to those for controls, suggesting that the ARTS sequence variant has no significant effect on protein expression and may be considered to be a polymorphism (data not shown).
We conclude that the absence of annulus in the patient is not due to defective expression of the mRNAs encoding known annulus structural components (Sept1, Sept4, Sept6, Sept7, Sept12 and Tat1) nor to deleterious mutations in TAT1 or SEPT4 genes.
Discussion
TAT1 is an anion transporter of the SLC26 family; it is specifically expressed in male germ cells and co-expressed with Sept4, a member of the Septin GTPases family, at the annulus of both human and mouse sperm. In the mouse, inactivation of Tat1 and Sept4 results in total male sterility. The phenotypes of both mutant mouse models display an absence of sperm motility with MP -PP disjunction and hairpin-like bending of the flagella. Tat1 null sperm also have an atrophic annulus structure and Sept4 null sperm lack the entire annulus structure.
We used our antibody directed against TAT1 to analyze a cohort of 75 asthenozoospermic patients and found one patient whose sperm displayed an absence of the annulus structure together with the absence of annulus molecular components, MP -PP disjunction and disorganization of the mitochondrial sheath.
Frequency of the loss of annulus in human asthenozoospermia
A previous immunocytochemical study in a smaller Japanese asthenozoospermic cohort (isolated asthenozoospermia, n ¼ 15; oligoasthenozoospermia, n ¼ 5) reported three cases of isolated asthenozoospermia associated with a loss of the annulus. These findings suggested the existence of a high frequency of association of these sperm defects with asthenozoospermia and also that the annulus could be used as a marker for the diagnosis and the classification of asthenozoospermia (Ihara et al., 2005) . Here, we analyzed 75 cases of asthenozoospermia including 28 cases of isolated asthenozoospermia, 13 cases of oligo-asthenozoospermia and 34 cases of terato-asthenozoospermia, but found only one case of loss of annulus. Our analysis, therefore, suggests that the frequency of association in humans may be considerably lower than that initially expected. Whether this discrepancy may be attributed to the origin of the populations screened (Japanese versus Caucasian), to the small sizes of the two cohorts or to other causes remains to be determined. The analysis of additional cases should allow a better estimation of the frequency of this association.
Molecular origin of the annulus structural defects
The molecular causes of the structural defects observed in this patient remain unknown. The origin of the absence of annulus might be very complex and any of numerous genes may contribute, in particular, genes involved in the regulation of terminal flagellar differentiation and/or in annulus formation. However, there were no mutations in TAT1 or SEPT4 genes, and mRNA analysis indicates expression of the Septins constituting the sperm annulus. These findings suggested that the structural defects are not due to abnormal transcription of the known components of the annulus or to point mutations of the TAT1 and SEPT4 genes. Moreover, both SEPT4 and TAT1 proteins could be detected in whole extract from patient's blood and sperm, respectively, but neither of them could be detected at the annulus of the patient's spermatozoa. These results indicate that although TAT1 and SEPT4 proteins are expressed, they are not properly localized at sperm annulus. It is plausible that the correct localization of these proteins, and perhaps of all components of the annulus, is Figure 2 Protein hyperphosphorylation analysis during in vitro capacitation assay. Fresh semen samples from control subjects and from the case patient were incubated in capacitating medium for 3 h. Protein extracts collected at t ¼ 0 and t ¼ 3 h were subjected to western blot analysis with anti-phosphotyrosine antibody. The detection of normal hyperphosphorylation profile in sperm cells from the patient indicates that capacitation occurred normally.
under the control of a common, as yet unidentified, factor. This putative factor may be a guiding/anchoring transmembrane protein and may be implicated in the phenotype we describe here. Note also that a small proportion of the spermatozoa (3%) was normally labeled for Tat1 at the annulus, confirming that TAT1 and probably SEPT4 and SEPT7 proteins may have been expressed at earlier stages of spermatogenesis but failed to reach the annulus.
Discrepancy between human and mouse phenotypes
Despite severe structural abnormalities of the sperm concerning the annulus, the MP and the MP -PP connection, the patient displayed only moderate asthenozoospermia as evaluated by various standard methods. Furthermore, sperm penetration in cervical mucus was normal, hyperphosphorylation under capacitating conditions was also normal and the partner of the patient achieved a natural pregnancy.
Interestingly, the absence of the annulus did not result in hairpin-like bending of the patient's sperm flagella, unlike mouse Sept4 null sperm (absent annulus) or Tat1 null sperm (atrophic annulus). Indeed, this morphological abnormality (which is clearly distinct from flagella bent at the neck) is not a frequent feature of human teratozoospermia (Chemes and Rawe, 2003; Kubo-Irie et al., 2005) .
Possibly the annulus abnormalities in this patient have only limited effects on sperm motility and fertilizing ability because secondary Lack of annulus in moderate asthenozoospermia bending of the flagella does not occur. This difference from the mouse models may result from dissimilar behaviors of the spermatid residual body in mouse and human. Indeed, the residual body in human is mostly eliminated in the testis (Holstein and Roosen Runge, 1981) , whereas in the mouse a remnant of the residual body, called cytoplasmic droplet, migrates from the connecting piece toward the annulus and late in the epididymis forms a drop on one side extending along the MP (Cooper, 2005) . Consistent with this view, we previously observed that in Tat1-deficient mouse, the hairpin-like flagellar bending occurs at the annulus, during sperm transit in the epididymis and results in the rupture of the axonemal structures. Furthermore, work in Cooper's laboratory indicates that mouse sperm is more sensitive to osmotic deregulation of the environment and that under these conditions, and unlike human sperm, mouse sperm can display a flagellar curve at the position of the annulus (Yeung et al., 1999 (Yeung et al., , 2002 (Yeung et al., , 2005 (Yeung et al., , 2006 .
In conclusion, we describe a case presenting molecular and ultrastructural anomalies affecting the annulus and clinically associated with moderate asthenozoospermia. The molecular causes of this phenotype remain unknown; however, the case we describe here has not been reported previously. This is the first time that the lack of annulus and disorganization of the MP -PP junction are associated with human asthenozoospermia. Moreover, this case complements the data obtained from mouse models displaying an atrophy of the annulus (Tat1 mouse model) or an absence of the annulus (Septin 4 model), and both leading to severe asthenozoospermia. We demonstrate that in human, like in the mouse, the integrity of the annulus is required for correct MP elongation and sperm motility. However, the consequences of the loss of annulus on fertility potential could differ between mice and men: in the mouse, loss of annulus abolishes sperm motility and fertility, whereas in human the effects of this anomaly are less severe. This difference could most likely be attributed to dissimilar epididymal maturation of spermatozoa, in particular, to the existence of the cytoplasmic droplet at the annulus of mouse spermatozoa and its elimination during epididymal transit, a process that does not occur in human.
The annulus is a structure which was described 40 years ago by Holstein, based on electron microscopy observations, but the function of which has been far from clear. This study gives first clues as to the functions of the annulus in human spermatozoa.
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